BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The Most Notable Design Brands of the 21st Hundred years - 2Holiday weather forecast: Where travelers can expect a wintry mix, flooding and record warmth across the U.S.
- 3Horses really can smell our fear, new study finds
- 4In the background: Visiting Notable Film Areas All over the Planet
- 5Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- Tech for Wellbeing: Applications and Devices for a Better You
- $2,000 tariff rebate checks? 50-year mortgages? Making sense of Trump's new 'affordability' proposals.
- Interpreter Starts Sobbing as 11-Year-Old Testifies About Last Time He Saw His Mom Before She Was Killed in Missile Strike
- Russia Creates New Military Branch Dedicated To Drone Warfare
- Study shows no clear link between low-fat dairy and dementia risk
- Muslim Brotherhood stole half a billion dollars in Gaza donations, Arab sources reveal
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- Which Exhibition hall Do You Suggest? Vote
- Air Force made critical errors during October 7 massacre, investigator says
